BUSULPHAN IN TREATMENT OF CHRONIC GRANULOCYTIC LEUKAEMIA

[1] MYLERAN AND TRIETHYLENE MELAMINE IN THE TREATMENT OF CHRONIC GRANULOCYTIC LEUKEMIA [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 996 - 1000

[2] MYLERAN IN TREATMENT OF CHRONIC MYELOID LEUKAEMIA [J]. BRITISH MEDICAL JOURNAL, 1956, 1 (APR14) : 835 - 837

[3] DAMESHEK W, 1958, LEUKAEMIA

[4] BUSULFAN (1,4-DIMETHANESULFONYLOXYBUTANE, MYLERAN) - SUMMARY OF CLINICAL RESULTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 967 - 973

[5] GALTON DAG, 1953, LANCET, V1, P208

[6] GHOSE S, 1960, J Indian Med Assoc, V34, P381

[7] GREIG H. B. W., 1956, ACTA HAEMATOL, V16, P171

[8] HADDOW A, 1953, LANCET, V1, P207

[9] HAUT A, 1961, BLOOD, V17, P1

[10] MEDULLARY APLASIA IN CHRONIC MYELOID LEUKAEMIA DURING BUSULPHAN THERAPY [J]. BRITISH MEDICAL JOURNAL, 1957, 2 (DEC21) : 1468 - 1471

[1] MYLERAN AND TRIETHYLENE MELAMINE IN THE TREATMENT OF CHRONIC GRANULOCYTIC LEUKEMIA [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 996 - 1000

[2] MYLERAN IN TREATMENT OF CHRONIC MYELOID LEUKAEMIA [J]. BRITISH MEDICAL JOURNAL, 1956, 1 (APR14) : 835 - 837

[3] DAMESHEK W, 1958, LEUKAEMIA

[4] BUSULFAN (1,4-DIMETHANESULFONYLOXYBUTANE, MYLERAN) - SUMMARY OF CLINICAL RESULTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1958, 68 (03) : 967 - 973

[5] GALTON DAG, 1953, LANCET, V1, P208

[6] GHOSE S, 1960, J Indian Med Assoc, V34, P381

[7] GREIG H. B. W., 1956, ACTA HAEMATOL, V16, P171

[8] HADDOW A, 1953, LANCET, V1, P207

[9] HAUT A, 1961, BLOOD, V17, P1

[10] MEDULLARY APLASIA IN CHRONIC MYELOID LEUKAEMIA DURING BUSULPHAN THERAPY [J]. BRITISH MEDICAL JOURNAL, 1957, 2 (DEC21) : 1468 - 1471